<?xml version='1.0' encoding='UTF-8'?>
<Organism_Record>
  <Organism_ID>ASD05850000_1</Organism_ID>
  <Organism>Human</Organism>
  <Organism_Latin>Homo sapiens</Organism_Latin>
  <UniProt_ID>P63279</UniProt_ID>
  <Seq_Length>158</Seq_Length>
  <Molecule_Weight>18007</Molecule_Weight>
  <KEGG_ID>hsa:7329</KEGG_ID>
  <Orthology_ID>K10577</Orthology_ID>
  <EBI_ID>EBI-80168</EBI_ID>
  <Function_Summary>Accepts the ubiquitin-like proteins SUMO1, SUMO2, SUMO3 and SUMO4 from the UBLE1A-UBLE1B E1 complex and catalyzes their covalent attachment to other proteins with the help of an E3 ligase such as RANBP2 or CBX4. Can catalyze the formation of poly-SUMO chains. Necessary for sumoylation of FOXL2 and KAT5. Essential for nuclear architecture and chromosome segregation.</Function_Summary>
  <Catalytic_Mechanism>ATP + SUMO + protein lysine = AMP + diphosphate + protein N-SUMOyllysine.</Catalytic_Mechanism>
  <Pfam_ID>PF00179:UQ_con</Pfam_ID>
  <Allosteric_Activator_Count>0</Allosteric_Activator_Count>
  <Allosteric_Inhibitor_Count>0</Allosteric_Inhibitor_Count>
  <Allosteric_Regulator_Count>0</Allosteric_Regulator_Count>
  <Alias_List>
      <Alias>p18</Alias>
      <Alias>Ubiquitin carrier protein 9</Alias>
      <Alias>Ubiquitin-protein ligase I</Alias>
      <Alias>Ubiquitin-conjugating enzyme E2 I</Alias>
      <Alias>SUMO-protein ligase</Alias>
      <Alias>Ubiquitin carrier protein I</Alias>
  </Alias_List>
  <Function_List>
    <Funtion>
      <Detail>Catalysis of the joining of two substances, or two groups within a single molecule, with the concomitant hydrolysis of the diphosphate bond in ATP or a similar triphosphate.</Detail>
      <Keyword>Ligase activity</Keyword>
      <Ontology_ID>GO:0016874</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.</Detail>
      <Keyword>ATP binding</Keyword>
      <Ontology_ID>GO:0005524</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Catalysis of the reaction: ATP + ubiquitin + protein lysine = AMP + diphosphate + protein N-ubiquityllysine.</Detail>
      <Keyword>Ubiquitin-protein ligase activity</Keyword>
      <Ontology_ID>GO:0004842</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with a nucleotide, any compound consisting of a nucleoside that is esterified with (ortho)phosphate or an oligophosphate at any hydroxyl group on the ribose or deoxyribose.</Detail>
      <Keyword>Nucleotide binding</Keyword>
      <Ontology_ID>GO:0000166</Ontology_ID>
    </Funtion>
    <Funtion>
      <Detail>Interacting selectively and non-covalently with any enzyme.</Detail>
      <Keyword>Enzyme binding</Keyword>
      <Ontology_ID>GO:0019899</Ontology_ID>
    </Funtion>
  </Function_List>
  <BioProcess_List>
    <BioProcess>
      <Detail>A cell cycle process comprising the steps by which the nucleus of a eukaryotic cell divides; the process involves condensation of chromosomal DNA into a highly compacted form. Canonically, mitosis produces two daughter nuclei whose chromosome complement is identical to that of the mother cell.</Detail>
      <Keyword>Mitosis</Keyword>
      <Ontology_ID>GO:0007067</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which a SUMO protein (small ubiquitin-related modifier) is conjugated to a target protein via an isopeptide bond between the carboxyl terminus of SUMO with an epsilon-amino group of a lysine residue of the target protein.</Detail>
      <Keyword>Protein sumoylation</Keyword>
      <Ontology_ID>GO:0016925</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process resulting in the physical partitioning and separation of a cell into daughter cells.</Detail>
      <Keyword>Cell division</Keyword>
      <Ontology_ID>GO:0051301</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process that stops, prevents, or reduces the frequency, rate or extent of transcription from an RNA polymerase II promoter.</Detail>
      <Keyword>Negative regulation of transcription from RNA polymerase II promoter</Keyword>
      <Ontology_ID>GO:0000122</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The process in which genetic material, in the form of chromosomes, is organized into specific structures and then physically separated and apportioned to two or more sets. In eukaryotes, chromosome segregation begins with the alignment of chromosomes at the metaphase plate, includes chromosome separation, and ends when chromosomes have completed movement to the spindle poles.</Detail>
      <Keyword>Chromosome segregation</Keyword>
      <Ontology_ID>GO:0007059</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Protein involved in ubiquitin-like modifier processing, activation, conjugation or deconjugation such as Ubl-activating enzymes (E1s), Ubl-conjugating enzymes (E2s), Ubl-protein ligases (E3s), some thiol proteases (Ubiquitin carboxyl-terminal hydrolases (UCH), Ubiquitin-specific processing proteases (UBP) and ubiquitin-like proteases) and the ubiquitin-like modifier proteins. Besides signaling proteolysis, ubiquitination for example can be a signal for trafficking, kinase activation and other nonproteolytic fates.</Detail>
      <Keyword>Ubl conjugation pathway</Keyword>
      <Ontology_ID>KW-0833</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>Any process in which an organism has an effect on an organism of a different species.</Detail>
      <Keyword>Interspecies interaction between organisms</Keyword>
      <Ontology_ID>GO:0044419</Ontology_ID>
    </BioProcess>
    <BioProcess>
      <Detail>The progression of biochemical and morphological phases and events that occur in a cell during successive cell replication or nuclear replication events. Canonically, the cell cycle comprises the replication and segregation of genetic material followed by the division of the cell, but in endocycles or syncytial cells nuclear replication or nuclear division may not be followed by cell division.</Detail>
      <Keyword>Cell cycle</Keyword>
      <Ontology_ID>GO:0007049</Ontology_ID>
    </BioProcess>
  </BioProcess_List>
  <PTM_List>
    <PTM>
      <Position>65</Position>
      <PTM_Type>N6-acetyllysine</PTM_Type>
    </PTM>
  </PTM_List>
  <Molecule_Seq>
    <Protein_Seq>MSGIALSRLAQERKAWRKDHPFGFVAVPTKNPDGTMNLMNWECAIPGKKGTPWEGGLFKLRMLFKDDYPSSPPKCKFEPPLFHPNVYPSGTVCLSILEEDKDWRPAITIKQILLGIQELLNEPNIQDPAQAEAYTIYCQNRVEYEKRVRAQAKKFAPS</Protein_Seq>
    <DNA_Seq>GCCCGCGCCAGGGTCCTCGGAGCTGCTCTGGCTGCGCGCGGAGCGGGCTCCGGAGGGAAGTCCCGAGACAAAGGGAAGCGCCGCCGCCGCCGCCCCGCTCGGTCCTCCACCTGTCCGCTACGCTCGCCGGGGCTGCGGCCGCCCGAGGGACTTTGAACATGTCGGGGATCGCCCTCAGCAGACTCGCCCAGGAGAGGAAAGCATGGAGGAAAGACCACCCATTTGGTTTCGTGGCTGTCCCAACAAAAAATCCCGATGGCACGATGAACCTCATGAACTGGGAGTGCGCCATTCCAGGAAAGAAAGGGACTCCGTGGGAAGGAGGCTTGTTTAAACTACGGATGCTTTTCAAAGATGATTATCCATCTTCGCCACCAAAATGTAAATTCGAACCACCATTATTTCACCCGAATGTGTACCCTTCGGGGACAGTGTGCCTGTCCATCTTAGAGGAGGACAAGGACTGGAGGCCAGCCATCACAATCAAACAGATCCTATTAGGAATACAGGAACTTCTAAATGAACCAAATATCCAAGACCCAGCTCAAGCAGAGGCCTACACGATTTACTGCCAAAACAGAGTGGAGTACGAGAAAAGGGTCCGAGCACAAGCCAAGAAGTTTGCGCCCTCATAAGCAGCGACCTTGTGGCATCGTCAAAAGGAAGGGATTGGTTTGGCAAGAACTTGTTTACAACATTTTTGCAAATCTAAAGTTGCTCCATACAATGACTAGTCACCTGGGGGGGTTGGGCGGGCGCCATCTTCCATTGCCGCCGCGGGTGTGCGGTCTCGATTCGCTGAATTGCCCGTTTCCATACAGGGTCTCTTCCTTCGGTCTTTTGTATTTTTGATTGTTATGTAAAACTCGCTTTTATTTTAATATTGATGTCAGTATTTCAACTGCTGTAAAATTATAAACTTTTATACTTGGGTAAGTCCCCCAGGGGCGAGTTCCTCGCTCTGGGATGCAGGCATGCTTCTCACCGTGCAGAGCTGCACTTGGCCTCAGCTGGCTGTATGGAAATGCACCCTCCCTCCTGCCGCTCCTCTCTAGAACCTTCTAGAACCTGGGCTGTGCTGCTTTTGAGCCTCAGACCCCAGGTCAGCATCTCGGTTCTGCGCCACTTCCTTTGTGTTTATATGGCGTTTTGTCTGTGTTGCTGTTTAGAGTAAATAAACTGTTTATATAAAGGTTTTGGTTGCATTATTATCATTGAAAGTGAGAGGAGGCGGCCTCCCAGTGCCCGGCCCTCCCCACCCACCTGCAGCCCCACCGCGGGCCAGGACCAGGCTCTCCATCTGCTTCGGATGCACGCAGGCTGTGAGGCTCTGTCTTGCCCTGGATCTTTGTAAACAGGGCTGTGTACAAAGTGCTGCTGAGGTTTCTGTGCTCCCCGCATCTGCGGGCTGTAGAGCGCTGGGCAGCTAAGATCTGCATAGGTCGGGATTGGCATCGAGACCCTGGCAACTGCACCGGTGCCAGCTGTCTTGGGGGCCACAAGGCCAGGTCCAGACCAGGGCTGGGGGCTGCCTGAGGACTCCTATCCGGGCAGCCTGCTGGCGGGGGTTCCCCTCTTCAGTGGCCAGGTCACAGGGATGGAGCTGCGCTGTGCATAGGGTGCCACCTCAGGTGTCTGTCCCTTGTGTCCTCAGGAGGCAGCCTTGCTACCACCCGTGGCAAACGCCAGGTGCTTTTTCTGGGAGAGCCCACAGCCGTGGCCCTCCAGGGCTTCCCCGACCCTTAGCGCCAGGTAGAGGGCCCTGGGCAGCCTGTGTCTGGAATTCTTCGTCCTGAGGCCACCTGAGTGTGGTCTGTCCTGGGGAGGCTGTGCGCCTCAGCAGCCGTCCTGACGCTGAGCCCTCTGCAAAGGTTGGGCCGGCCAGGCCTCTTGGGGCTGCCTGAGCCACTGCAGGAAGTGGCCTGGCTGGGAAGTTGGGTGCCGGTCACCTCCCAGCAGGAAGGCACAGTGGACAGAGATGGGAAGCCCTGGGGGACACAGCCCGGTGCTCCCAGCCCTCCAACCTCTGGCTCCCAACCCAGTCTCCCCATCCTAGCGAGCTTGGCCCTCCTCAGTTTCGTTTCAAGCCTTGGGGCTGGAGCTGGCCCTGCTGCCCTGGCACCCCCCGGTGGCTGGAGCTGGGTCCCCGTGGCCCAAGTGCAGGGTCCCAAGAGGGCAGGGCGGGGCTCCCCAAAGGAGCAAAGAATGCAGGGAGGGCGGTCCAGGGCCCTGGGAAGGGGAGCTCGGCACCCTCCAGGTCCGTGTGGGACTCCAGCCGCTGTTGGCTGGGAATCGAAGTTAGAGGTGACTTCCAAAGGCCCCCCGAGCCGGCAGTGCCCCCCACCACCCCTCCAGCGACTCTGCGGTGCCAGTGCCTTGTTGGCTTTTCCGGCTACGCACCCTGCAGTCACTGAGCTCTCGGTCTGACGTCTGATGTTTGTGGTTTGTTTATAACACGGGGCCTTACCTGGGGAATTCAGCTGGTTTGAATATTTGTAGCCCGCTCCCAGAATGTCTTATTTTGTAATGACTGAACTACATTTAGTAATAGTTACACATGTATATGGTTAATACATATGGAAATTCAATATATTTTGTAGTTAACGTATTCTGAAGTAACGGATGTTTCTCGCCAATCGTAGTGACTTCAGCTAACGAAATGTTCTTTTGTAGTACCACGGTCCTCGGCCTAACGAAGGACGTGAACCTTGTAAGAGGAGAGCTCTGAAACGCGGTCACCTTTGTTTAGTGGAAGGGAAAGTGTGTTCCCGGCATGAGGTGCCTCGGAATTAGTAAAGAATTGTGGGCAATGGATTAACCACTGTATCTAAGAATCCACCATTAAAGCATTTGCACAGACAAAAAAAAAAA</DNA_Seq>
  </Molecule_Seq>
  <Tissuelocal_List>
    <TissueLocal>
      <TissueLocal>Kidney</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Testis</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Skeletal muscle</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Heart</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Brain</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Placenta</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Lung</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Thymus</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Liver</TissueLocal>
    </TissueLocal>
    <TissueLocal>
      <TissueLocal>Pancreas</TissueLocal>
    </TissueLocal>
  </Tissuelocal_List>
  <CellLocal_List>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Synaptonemal complex</CellLocal>
      <Ontology_ID>GO:0000795</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>PML body</CellLocal>
      <Ontology_ID>GO:0016605</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Cytoplasm</CellLocal>
      <Ontology_ID>GO:0005737</Ontology_ID>
    </AsdMacromoleculeCelllocal>
    <AsdMacromoleculeCelllocal>
        <CellLocal>Nucleus</CellLocal>
      <Ontology_ID>GO:0005634</Ontology_ID>
    </AsdMacromoleculeCelllocal>
  </CellLocal_List>
  <Gene>
    <Gene_Name>UBE2I</Gene_Name>
    <Gene_Alias>UBC9; UBCE9</Gene_Alias>
    <Gene_ID>7329</Gene_ID>
    <Genbank_ACCN>NM_003345</Genbank_ACCN>
    <Protein_ACCN>NP_003336</Protein_ACCN>
    <HGNC_ID>12485</HGNC_ID>
    <Gene_URL>http://www.ncbi.nlm.nih.gov/gene/7329</Gene_URL>
    <UCSC_ID>uc002clc.2</UCSC_ID>
    <EMBL_ID>ENSG00000103275</EMBL_ID>
  </Gene>
  <PPI_List>
    <PPI>
      <Uniprot_ID>Q13485</Uniprot_ID>
      <Gene_Name>SMAD4</Gene_Name>
      <EBI_ID>EBI-347263</EBI_ID>
      <PPI_EBI_URL>EBI-80168,EBI-347263</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9Y3V2</Uniprot_ID>
      <Gene_Name>RWDD3</Gene_Name>
      <EBI_ID>EBI-1549885</EBI_ID>
      <PPI_EBI_URL>EBI-80168,EBI-1549885</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>P22314</Uniprot_ID>
      <Gene_Name>UBA1</Gene_Name>
      <EBI_ID>EBI-709688</EBI_ID>
      <PPI_EBI_URL>EBI-80168,EBI-709688</PPI_EBI_URL>
      <Experiment_Number>2</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O14503</Uniprot_ID>
      <Gene_Name>BHLHE40</Gene_Name>
      <EBI_ID>EBI-711810</EBI_ID>
      <PPI_EBI_URL>EBI-80168,EBI-711810</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q9UBC3</Uniprot_ID>
      <Gene_Name>DNMT3B</Gene_Name>
      <EBI_ID>EBI-80125</EBI_ID>
      <PPI_EBI_URL>EBI-80168,EBI-80125</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>Q92754</Uniprot_ID>
      <Gene_Name>TFAP2C</Gene_Name>
      <EBI_ID>EBI-937309</EBI_ID>
      <PPI_EBI_URL>EBI-80168,EBI-937309</PPI_EBI_URL>
      <Experiment_Number>3</Experiment_Number>
    </PPI>
    <PPI>
      <Uniprot_ID>O75928</Uniprot_ID>
      <Gene_Name>PIAS2</Gene_Name>
      <EBI_ID>EBI-348555</EBI_ID>
      <PPI_EBI_URL>EBI-80168,EBI-348555</PPI_EBI_URL>
      <Experiment_Number>5</Experiment_Number>
    </PPI>
  </PPI_List>
  <PDB_List>
    <PDB>
      <PDB_Title>Crystal structure of a complex between UBC9, SUMO-1, RANGAP1 and NUP358/RANBP2</PDB_Title>
      <PDB_ID>1Z5S</PDB_ID>
      <Resolution>3.01</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1Z5S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358 complex.</PubMed_Title>
      <Author>Reverter, D., et al.</Author>
      <Journal>Nature(2005)435:687-692</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/15931224?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>CRYSTAL STRUCTURE OF IMPORTIN 13 - UBC9 COMPLEX</PDB_Title>
      <PDB_ID>2XWU</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2XWU</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of Importin13-Ubc9 Complex: Nuclear Import and Release of a Key Regulator of Sumoylation.</PubMed_Title>
      <Author>Gruenwald, M., et al.</Author>
      <Journal>Embo J.(2011)30:427-438</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/21139563?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>HUMAN UBC9</PDB_Title>
      <PDB_ID>1A3S</PDB_ID>
      <Resolution>2.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1A3S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure of ubiquitin-conjugating enzyme 9 displays significant differences with other ubiquitin-conjugating enzymes which may reflect its specificity for sumo rather than ubiquitin.</PubMed_Title>
      <Author>Giraud, M.F., et al.</Author>
      <Journal>Acta Crystallogr.,Sect.D(1998)54:891-898</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/9757105?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>The crystal structure of the SLD2:Ubc9 complex</PDB_Title>
      <PDB_ID>3A4S</PDB_ID>
      <Resolution>2.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3A4S</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for regulation of poly-SUMO chain by a SUMO-like domain of Nip45</PubMed_Title>
      <Author>Sekiyama, N., et al.</Author>
      <Journal>Proteins(2009)78:1491-1502</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/20077568?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex between human RanGAP1-SUMO2, UBC9 and the IR1 domain from RanBP2</PDB_Title>
      <PDB_ID>3UIN</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3UIN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Determinants of SUMO1 specificity, E3 ligase and SUMO-RanGAP1 binding activities of the nucleoporin RanBP2.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of human RanGAP1-Ubc9-D127S</PDB_Title>
      <PDB_ID>2GRR</PDB_ID>
      <Resolution>1.3</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GRR</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.</PubMed_Title>
      <Author>Yunus, A.A., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2006)13:491-499</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16732283?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Structural Basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin conjugating enzyme Ubc9 and RanGAP1</PDB_Title>
      <PDB_ID>1KPS</PDB_ID>
      <Resolution>2.5</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=1KPS</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structural basis for E2-mediated SUMO conjugation revealed by a complex between ubiquitin-conjugating enzyme Ubc9 and RanGAP1.</PubMed_Title>
      <Author>Bernier-Villamor, V., et al.</Author>
      <Journal>Cell(Cambridge,Mass.)(2002)108:345-356</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/11853669?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of human RanGAP1-Ubc9-N85Q</PDB_Title>
      <PDB_ID>2GRO</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GRO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.</PubMed_Title>
      <Author>Yunus, A.A., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2006)13:491-499</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16732283?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of human RanGAP1-Ubc9-Y87A</PDB_Title>
      <PDB_ID>2GRP</PDB_ID>
      <Resolution>2.05</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GRP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.</PubMed_Title>
      <Author>Yunus, A.A., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2006)13:491-499</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16732283?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Ubiquitin-Conjugating Enzyme E2-25 kDa Complexed With SUMO-1-Conjugating Enzyme UBC9</PDB_Title>
      <PDB_ID>2O25</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2O25</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>A Novel and Unexpected Complex Between the SUMO-1-Conjugating Enzyme UBC9 and the Ubiquitin-Conjugating Enzyme E2-25 kDa</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Complex between human RanGAP1-SUMO1, UBC9 and the IR1 domain from RanBP2 containing IR2 Motif II</PDB_Title>
      <PDB_ID>3UIP</PDB_ID>
      <Resolution>2.29</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3UIP</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Determinants of SUMO1 specificity, E3 ligase and SUMO-RanGAP1 binding activities of the nucleoporin RanBP2.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of human RanGAP1-Ubc9-D127A</PDB_Title>
      <PDB_ID>2GRQ</PDB_ID>
      <Resolution>1.7</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GRQ</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.</PubMed_Title>
      <Author>Yunus, A.A., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2006)13:491-499</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16732283?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Complex between human RanGAP1-SUMO2, UBC9 and the IR1 domain from RanBP2 containing IR2 Motif II</PDB_Title>
      <PDB_ID>3UIO</PDB_ID>
      <Resolution>2.6</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=3UIO</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Determinants of SUMO1 specificity, E3 ligase and SUMO-RanGAP1 binding activities of the nucleoporin RanBP2.</PubMed_Title>
    </PDB>
    <PDB>
      <PDB_Title>The intrinsic affinity between E2 and the Cys domain of E1 in Ubiquitin-like modifications</PDB_Title>
      <PDB_ID>2PX9</PDB_ID>
      <Resolution>-1.0</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PX9</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>The intrinsic affinity between E2 and the Cys domain of E1 in ubiquitin-like modifications.</PubMed_Title>
      <Author>Wang, J., et al.</Author>
      <Journal>Mol.Cell(2007)27:228-237</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17643372?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Crystal Structure of human RanGAP1-Ubc9</PDB_Title>
      <PDB_ID>2GRN</PDB_ID>
      <Resolution>1.8</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2GRN</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Lysine activation and functional analysis of E2-mediated conjugation in the SUMO pathway.</PubMed_Title>
      <Author>Yunus, A.A., et al.</Author>
      <Journal>Nat.Struct.Mol.Biol.(2006)13:491-499</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/16732283?dopt=Abstract</PubMed_ID>
    </PDB>
    <PDB>
      <PDB_Title>Non-covalent complex between human SUMO-1 and human Ubc9</PDB_Title>
      <PDB_ID>2PE6</PDB_ID>
      <Resolution>2.4</Resolution>
      <PDB_URL>http://www.pdb.org/pdb/explore/explore.do?structureId=2PE6</PDB_URL>
      <Has_Ligand>No</Has_Ligand>
      <PubMed_Title>Structure and Analysis of a Complex between SUMO and Ubc9 Illustrates Features of a Conserved E2-Ubl Interaction.</PubMed_Title>
      <Author>Capili, A.D., et al.</Author>
      <Journal>J.Mol.Biol.(2007)369:608-618</Journal>
      <PubMed_ID>http://www.ncbi.nlm.nih.gov/pubmed/17466333?dopt=Abstract</PubMed_ID>
    </PDB>
  </PDB_List>
  <Network_List>
    <Network>
      <Pathway_ID>ko04064</Pathway_ID>
      <Pathway_Title>NF-kappa B signaling pathway</Pathway_Title>
      <Pathway_Class>Environmental Information Processing</Pathway_Class>
      <Pathway_Subclass>Signal transduction</Pathway_Subclass>
    </Network>
    <Network>
      <Pathway_ID>ko05206</Pathway_ID>
      <Pathway_Title>MicroRNAs in cancer</Pathway_Title>
      <Pathway_Class>Human Diseases</Pathway_Class>
      <Pathway_Subclass>Cancers</Pathway_Subclass>
    </Network>
  </Network_List>
  <Fold>
    <SCOP_Class>Alpha and beta proteins (a+b)</SCOP_Class>
    <SCOP_URL>http://scop.mrc-lmb.cam.ac.uk/scop/data/scop.b.e.ei.b.b.bb.html</SCOP_URL>
    <CATH_Class>Class 3: Mixed Alpha-Beta</CATH_Class>
    <CATH_URL>http://www.cathdb.info/pdb/1kps</CATH_URL>
  </Fold>
  <AllostericSite_List>
    <AllostericSite>
      <Site_Type>Protein-induced</Site_Type>
    </AllostericSite>
  </AllostericSite_List>
  <Enzyme_Nomenclature_List>
    <Enzyme_Nomenclature>
      <Enzyme_DB_ID>6.3.2.-</Enzyme_DB_ID>
      <Enzyme_DB_URL>http://www.chem.qmul.ac.uk/iubmb/enzyme/EC6/3/2/-.html</Enzyme_DB_URL>
    </Enzyme_Nomenclature>
  </Enzyme_Nomenclature_List>
  <Create_Date>2012-06-20</Create_Date>
</Organism_Record>